298 related articles for article (PubMed ID: 26302862)
21. Vancomycin hydrochloride-loaded stearic acid/lauric acid in situ forming matrix for antimicrobial inhibition in patients with joint infection after total knee arthroplasty.
Chantadee T; Sawangsri P; Santimaleeworagun W; Phaechamud T
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():110761. PubMed ID: 32600673
[TBL] [Abstract][Full Text] [Related]
22. Levofloxacin HCl-Incorporated Zein-Based Solvent Removal Phase Inversion In Situ Forming Gel for Periodontitis Treatment.
Senarat S; Rojviriya C; Puyathorn N; Lertsuphotvanit N; Phaechamud T
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111684
[TBL] [Abstract][Full Text] [Related]
23. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
[TBL] [Abstract][Full Text] [Related]
24. Effect of polymer type on the dynamics of phase inversion and drug release in injectable in situ gelling systems.
Liu H; Venkatraman SS
J Biomater Sci Polym Ed; 2012; 23(1-4):251-66. PubMed ID: 21244721
[TBL] [Abstract][Full Text] [Related]
25. Nitrocellulose for Prolonged Permeation of Levofloxacin HCl-Salicylic Acid In Situ Gel.
Khaing EM; Jitrangsri K; Chomto P; Phaechamud T
Polymers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611247
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of mechanical and rheological properties of metronidazole gel as local delivery system.
Jelvehgari M; Montazam H
Arch Pharm Res; 2011 Jun; 34(6):931-40. PubMed ID: 21725814
[TBL] [Abstract][Full Text] [Related]
27. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
Kilicarslan M; Koerber M; Bodmeier R
Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
[TBL] [Abstract][Full Text] [Related]
28. Formulation development of physiological environment responsive periodontal drug delivery system for local delviery of metronidazole benzoate.
Dabhi MR; Sheth NR
Drug Dev Ind Pharm; 2013 Mar; 39(3):425-36. PubMed ID: 22393879
[TBL] [Abstract][Full Text] [Related]
29. Doxycycline hydrochloride-metronidazole solid lipid microparticles gels for treatment of periodontitis: development, in-vitro and in-vivo clinical evaluation.
Gad HA; Kamel AO; Ezzat OM; El Dessouky HF; Sammour OA
Expert Opin Drug Deliv; 2017 Nov; 14(11):1241-1251. PubMed ID: 28485988
[TBL] [Abstract][Full Text] [Related]
30. Viscoelastic behavior of cellulose acetate in a mixed solvent system.
Appaw C; Gilbert RD; Khan SA; Kadla JF
Biomacromolecules; 2007 May; 8(5):1541-7. PubMed ID: 17458930
[TBL] [Abstract][Full Text] [Related]
31. Texture and topography analysis of doxycycline hyclate thermosensitive systems comprising zinc oxide.
Phaechamud T; Mahadlek J; Charoenteeraboon J
Indian J Pharm Sci; 2013 Jul; 75(4):385-92. PubMed ID: 24302791
[TBL] [Abstract][Full Text] [Related]
32. Solvent removal precipitation based in situ forming implant for controlled drug delivery in periodontitis.
Juvekar S; Kathpalia H
J Control Release; 2017 Apr; 251():75-81. PubMed ID: 28242417
[No Abstract] [Full Text] [Related]
33. Multiparticulate based thermosensitive intra-pocket forming implants for better treatment of bacterial infections in periodontitis.
Yadav SK; Khan G; Bansal M; Thokala S; Bonde GV; Upadhyay M; Mishra B
Int J Biol Macromol; 2018 Sep; 116():394-408. PubMed ID: 29746970
[TBL] [Abstract][Full Text] [Related]
34. Phase Inversion-Based Doxycycline Hyclate-Incorporated Borneol In Situ Gel for Periodontitis Treatment.
Lertsuphotvanit N; Tuntarawongsa S; Chantadee T; Phaechamud T
Gels; 2023 Jul; 9(7):. PubMed ID: 37504434
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonication-assisted preparation and characterization of emulsions and emulsion gels for topical drug delivery.
Singh VK; Behera B; Pramanik K; Pal K
J Pharm Sci; 2015 Mar; 104(3):1035-44. PubMed ID: 25470664
[TBL] [Abstract][Full Text] [Related]
36. Levofloxacin HCl-Loaded Eudragit L-Based Solvent Exchange-Induced In Situ Forming Gel Using Monopropylene Glycol as a Solvent for Periodontitis Treatment.
Senarat S; Tuntarawongsa S; Lertsuphotvanit N; Rojviriya C; Phaechamud T; Chantadee T
Gels; 2023 Jul; 9(7):. PubMed ID: 37504462
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization and evaluation of tinidazole-loaded mPEG-PDLLA (10/90) in situ gel forming system for periodontitis treatment.
Tian Y; Shen Y; Jv M
Drug Deliv; 2016 Oct; 23(8):2726-2735. PubMed ID: 26289210
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.
Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH
Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449
[TBL] [Abstract][Full Text] [Related]
39. Comparative studies for ciprofloxacin hydrochloride pre-formed gels and thermally triggered (in situ) gels: in vitro and in vivo appraisal using a bacterial keratitis model in rabbits.
Abdelkader H; Mansour HF
Pharm Dev Technol; 2015 Jun; 20(4):410-6. PubMed ID: 24392945
[TBL] [Abstract][Full Text] [Related]
40. Subgingival delivery of oral debriding agents: a proof of concept.
Dunlap T; Keller DC; Marshall MV; Costerton JW; Schaudinn C; Sindelar B; Cotton JR
J Clin Dent; 2011; 22(5):149-58. PubMed ID: 22403980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
